Integrative survival-based molecular profiling of human pancreatic cancer.
about
CRNDE: A Long Non-Coding RNA Involved in CanceR, Neurobiology, and DEvelopmentA thirteen-gene expression signature predicts survival of patients with pancreatic cancer and identifies new genes of interest.A pathway-based classification of breast cancer integrating data on differentially expressed genes, copy number variations and microRNA target genesWNT7B mediates autocrine Wnt/β-catenin signaling and anchorage-independent growth in pancreatic adenocarcinoma.Follistatin promotes adipocyte differentiation, browning, and energy metabolismIntegrative analysis of multi-omics data for identifying multi-markers for diagnosing pancreatic cancer.MicroRNA-21 in pancreatic ductal adenocarcinoma tumor-associated fibroblasts promotes metastasisGenomic Variations in Pancreatic Cancer and Potential Opportunities for Development of New Approaches for Diagnosis and Treatment.High-throughput microRNA (miRNAs) arrays unravel the prognostic role of MiR-211 in pancreatic cancer.Six1 promotes proliferation of pancreatic cancer cells via upregulation of cyclin D1 expression.Low expression of the E3 ubiquitin ligase CBL confers chemoresistance in human pancreatic cancer and is targeted by epidermal growth factor receptor inhibition.A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinomaThe prognostic significance of Src and p-Src expression in patients with osteosarcomaPancreatic cancer patient survival correlates with DNA methylation of pancreas development genes.Comparative study on gene set and pathway topology-based enrichment methods.Inhibition of de novo Palmitate Synthesis by Fatty Acid Synthase Induces Apoptosis in Tumor Cells by Remodeling Cell Membranes, Inhibiting Signaling Pathways, and Reprogramming Gene Expression.Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinomaMaster Regulators of Oncogenic KRAS Response in Pancreatic Cancer: An Integrative Network Biology AnalysisCalcipotriol Targets LRP6 to Inhibit Wnt Signaling in Pancreatic Cancer.Cell intrinsic role of COX-2 in pancreatic cancer developmentIdentification and characterization of the gene expression profiles for protein coding and non-coding RNAs of pancreatic ductal adenocarcinomas.Comprehensive Dissection of Transcriptome Data and Regulatory Factors in Pancreatic Cancer Cells.PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.Prognostic value of microRNA-21 in pancreatic ductal adenocarcinoma: a meta-analysisStudy of Clinical Survival and Gene Expression in a Sample of Pancreatic Ductal Adenocarcinoma by Parsimony Phylogenetic Analysis.HOXB7 promotes invasion and predicts survival in pancreatic adenocarcinoma.Epigenetic research in cancer epidemiology: trends, opportunities, and challengesConstruction and analysis of dysregulated lncRNA-associated ceRNA network identified novel lncRNA biomarkers for early diagnosis of human pancreatic cancer.miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions.Loss of MTSS1 results in increased metastatic potential in pancreatic cancer.Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer.The conflicting roles of tumor stroma in pancreatic cancer and their contribution to the failure of clinical trials: a systematic review and critical appraisal.A comprehensive analysis of candidate genes and pathways in pancreatic cancer.RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long-term survival and reveals a role for ANGPTL4p85α is a microRNA target and affects chemosensitivity in pancreatic cancerThe acinar regulator Gata6 suppresses KrasG12V-driven pancreatic tumorigenesis in mice.Measurement of protein kinase B activity in single primary human pancreatic cancer cells.Selective inhibition of pancreatic ductal adenocarcinoma cell growth by the mitotic MPS1 kinase inhibitor NMS-P715.Molecular signatures of mRNAs and miRNAs as prognostic biomarkers in pancreatobiliary and intestinal types of periampullary adenocarcinomasMolecular subtypes in cancers of the gastrointestinal tract.
P2860
Q28391523-AA784A1A-596B-4B68-B967-C8A3DB2745CCQ30410836-C53DC405-C55E-4A9C-B57A-962CAA974F93Q30566202-8AE8D12B-7DDB-4083-BED9-855E635F5EB5Q30571825-0D0AC5E7-56E6-4290-9A18-344DD22C596FQ30572723-B830E9D4-D3B8-4973-B85E-26AAC0E7C855Q30990997-031EDC36-D5B4-4887-B341-4596ED3112A9Q31132024-4B85E11F-8DA2-467F-A76F-DEFCAB7A29ACQ33838679-22B97165-1C22-4DD2-893E-29EAAB9C5358Q34479270-361EB06D-BD7F-4F74-A276-549E8DADA58AQ34634833-3F20F0FE-3AAC-4394-BC1D-83382F71B5BCQ34861855-DF0A3898-60D6-47F0-82B3-58B249E84A8CQ34941883-0C0DA274-9B05-4670-914E-3AF04010BA41Q35161678-D551A069-9514-4182-B14A-A51F33CB7351Q35651346-1F07904F-689D-4A12-8AC2-6CC1E0288D0CQ35816462-A83011B0-3C77-4489-8E0D-71FE6F55DBC9Q36038735-5800451D-5082-4585-81FB-200EC20CCFAEQ36103351-D4A5E185-AA49-4D72-BA60-7244E723F106Q36264967-3DB90A3D-6DFD-49FA-9199-75CBE4E5BEE5Q36279579-EB9B3C8F-F43B-408A-B02F-E1E38BADD206Q36312997-37F35004-E636-45C9-B73E-0A7E64024040Q36326330-0AE2C085-21DF-4E20-B3D9-FD306CE25872Q36344287-12D79657-701A-4FE3-AA72-2E0DC9E1AE68Q36498128-84584DB7-030A-4373-8C79-E6B961F765D7Q36675556-BC5886FD-0F8E-459B-89DC-B02C03412F85Q37141896-50B2E77E-FA93-4A6D-998F-F6EAA493EDF1Q37401868-57C0F8CF-5DBC-4A08-8C05-43593820EC15Q37587537-C6FC6CA9-E471-415D-94FB-91CEB9984182Q37636634-22CD23F2-C5CD-4D47-93A2-8B00DBC08C7EQ37661923-BC08153E-AE07-4E8C-BE5D-B9CFC64F1EE0Q37725460-E1964A1E-7B6E-47B9-B96E-7BC08EF08BF6Q38021384-9156FC7B-DD39-4BFE-BA5C-9D5053738E08Q38310416-5F2076ED-D938-4CFD-AC16-03FEF7B3A2BBQ38470363-769881C9-0EF1-4E11-817A-2B204250B266Q38765467-97726117-57E9-4E10-912F-031FD9F4B369Q38890426-6AB8D142-B44F-4942-8E09-12336A4703AEQ38919135-782E82DD-836F-4CF8-8989-E0F2E81E2D92Q39005983-EE2DBDE4-8099-40EE-B246-20F72F68A1FEQ39053663-8CB822BA-C44F-4D1D-A305-DAD37590C15DQ39061625-86B8A122-5F1A-4D23-A76B-4B6F10E49214Q39235977-11E304BC-CEBA-4853-ADEB-B55210090265
P2860
Integrative survival-based molecular profiling of human pancreatic cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 January 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Integrative survival-based molecular profiling of human pancreatic cancer.
@en
Integrative survival-based molecular profiling of human pancreatic cancer.
@nl
type
label
Integrative survival-based molecular profiling of human pancreatic cancer.
@en
Integrative survival-based molecular profiling of human pancreatic cancer.
@nl
prefLabel
Integrative survival-based molecular profiling of human pancreatic cancer.
@en
Integrative survival-based molecular profiling of human pancreatic cancer.
@nl
P2093
P2860
P1476
Integrative survival-based molecular profiling of human pancreatic cancer.
@en
P2093
Anne Kovochich
Antreas Hindoyan
David W Dawson
James J Farrell
Joseph H Calvopina
Linh M Tran
Nanping Wu
Reginald Hill
Sanjeet G Patel
P2860
P304
P356
10.1158/1078-0432.CCR-11-1539
P407
P577
2012-01-18T00:00:00Z